Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kaider

Showing results (61-70 of 121) with videos related to

Pageof 13
Sort By:
Vaccine|January 4, 2001
Seroprevalence of diphtheria immunity among injured adults in AustriaS Marlovits, R Stocker, A Efstratiou, et al.
British Journal of Anaesthesia|July 25, 2009
Evaluation of stroke volume variation obtained by arterial pulse contour analysis to predict fluid responsiveness intraoperativelyD Lahner, B Kabon, C Marschalek, et al.
Cancer Letters|September 29, 1998
Influence of intratumoral basic fibroblast growth factor concentration on survival in ovarian cancer patientsA Obermair, P Speiser, K Reisenberger, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Lack of impact of platinum dose intensity on the outcome of ovarian cancer patients. 10-year results of a prospective randomised phase III study comparing carboplatin-cisplatin with cyclophosphamide-cisplatinCh Dittrich, P Sevelda, H Salzer, et al.
British Journal of Cancer|July 17, 1998
Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with suspected ovarian cancerA Obermair, C Tempfer, L Hefler, et al.
Anticancer Research|September 3, 1999
Modified true-color computer-assisted image analysis versus subjective scoring of estrogen receptor expression in breast cancer: a comparisonP D Kohlberger, F Breitenecker, A Kaider, et al.
Gynakologisch-Geburtshilfliche Rundschau|January 1, 1997
[Survival prognosis in ovarian carcinoma Figo stages III and IV: 1980-1985 versus 1986-1993. A comparison of 2 treatment periods]G Knappitsch, K Gruböck, H Salzer, et al.
American Journal of Obstetrics and Gynecology|March 21, 1998
Tumor angiogenesis in stage IB cervical cancer: correlation of microvessel density with survivalA Obermair, C Wanner, S Bilgi, et al.
British Journal of Cancer|May 6, 1998
The prognostic value of CD44 isoform expression in endometrial cancerC Tempfer, G Haeusler, A Kaider, et al.
International Journal of Cancer|July 17, 1995
Microvessel density and vessel invasion in lymph-node-negative breast cancer: effect on recurrence-free survivalA Obermair, C Kurz, K Czerwenka, et al.
Pageof 13

Showing results (61-70 of 121) with videos related to

Sort By:
Pageof 13
Vaccine|January 4, 2001
Seroprevalence of diphtheria immunity among injured adults in AustriaS Marlovits, R Stocker, A Efstratiou, et al.
British Journal of Anaesthesia|July 25, 2009
Evaluation of stroke volume variation obtained by arterial pulse contour analysis to predict fluid responsiveness intraoperativelyD Lahner, B Kabon, C Marschalek, et al.
Cancer Letters|September 29, 1998
Influence of intratumoral basic fibroblast growth factor concentration on survival in ovarian cancer patientsA Obermair, P Speiser, K Reisenberger, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Lack of impact of platinum dose intensity on the outcome of ovarian cancer patients. 10-year results of a prospective randomised phase III study comparing carboplatin-cisplatin with cyclophosphamide-cisplatinCh Dittrich, P Sevelda, H Salzer, et al.
British Journal of Cancer|July 17, 1998
Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with suspected ovarian cancerA Obermair, C Tempfer, L Hefler, et al.
Anticancer Research|September 3, 1999
Modified true-color computer-assisted image analysis versus subjective scoring of estrogen receptor expression in breast cancer: a comparisonP D Kohlberger, F Breitenecker, A Kaider, et al.
Gynakologisch-Geburtshilfliche Rundschau|January 1, 1997
[Survival prognosis in ovarian carcinoma Figo stages III and IV: 1980-1985 versus 1986-1993. A comparison of 2 treatment periods]G Knappitsch, K Gruböck, H Salzer, et al.
American Journal of Obstetrics and Gynecology|March 21, 1998
Tumor angiogenesis in stage IB cervical cancer: correlation of microvessel density with survivalA Obermair, C Wanner, S Bilgi, et al.
British Journal of Cancer|May 6, 1998
The prognostic value of CD44 isoform expression in endometrial cancerC Tempfer, G Haeusler, A Kaider, et al.
International Journal of Cancer|July 17, 1995
Microvessel density and vessel invasion in lymph-node-negative breast cancer: effect on recurrence-free survivalA Obermair, C Kurz, K Czerwenka, et al.
Pageof 13